2024-03-29T00:35:33Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_C847DAC2A00B
2024-03-23T02:58:16Z
serval:BIB_C847DAC2A00B
Choice of first line systemic treatment in pancreatic cancer among national experts.
10.1016/j.pan.2020.03.012
000572257600018
32299764
Glatzer
M.
author
Horber
D.
author
Montemurro
M.
author
Winterhalder
R.
author
Inauen
R.
author
Berger
M.D.
author
Pestalozzi
B.
author
Pederiva
S.
author
Pless
M.
author
Putora
P.M.
author
article
2020-06
Pancreatology
1424-3911
1424-3903
journal
20
4
686-690
Antineoplastic Agents/administration & dosage
Antineoplastic Agents/therapeutic use
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Clinical Decision-Making
Humans
Pancreatic Neoplasms/drug therapy
Pancreatic Neoplasms/epidemiology
Pancreatic Neoplasms/pathology
Switzerland/epidemiology
Decision criteria
FOLFIRINOX
Nab-paclitaxel
Pancreatic cancer
Treatment algorithm
decision-making
eng
60_published
peer-reviewed
Publication types: Journal Article
Publication Status: ppublish